8371 - 8380 of 9033 Results
Title
Year
-
OPENTitle: BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating TriglyceridesJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 4Start Page: 4763End Page: 4786Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c03046Best OA location URL: https://doi.org/10.1021/acs.jmedchem.4c03046Citation Count: 8
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
-
OPENTitle: Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 4Start Page: 357End Page: 367Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00029-3Best OA location URL: https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(26)00029-3.pdfCitation Count: 4
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?2019RESTRICTEDTitle: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 128Issue #: 4Start Page: 470End Page: 475Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001Citation Count: 41
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 41
-
OPENTitle: The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 90End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.005Best OA location URL: http://www.prd-journal.com/article/S1353802018301500/pdfCitation Count: 70
-
OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385752Citation Count: 55
-
OPENTitle: Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon ActivationJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167999End Page: 167999Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2023.167999Best OA location URL: https://doi.org/10.1016/j.jmb.2023.167999Citation Count: 23
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 115
-
OPENTitle: Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlx110Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/2/139/23373432/nlx110.pdfCitation Count: 50